Align Technology shares surge after Q4 EPS and revenues beat expectations, lifted by record Clear Aligner volumes, even as gross and operating margins fall.
Although the revenue and EPS for Align Technology (ALGN) give a sense of how its business performed in the quarter ended December 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Align Technology (ALGN) came out with quarterly earnings of $3.29 per share, beating the Zacks Consensus Estimate of $2.99 per share. This compares to earnings of $2.44 per share a year ago.
Get a deeper insight into the potential performance of Align Technology (ALGN) for the quarter ended December 2025 by going beyond Wall Street's top-and-bottom-line estimates and examining the estimates for some of its key metrics.
After reaching an important support level, Align Technology, Inc. (ALGN) could be a good stock pick from a technical perspective. ALGN recently experienced a "golden cross" event, which saw its 50-day simple moving average breaking out above its 200-day simple moving average.
ALGN heads into Q4 earnings with revenues likely to rise 3.9% and EPS up 22.5%, aided by Clear Aligner demand and scanner growth.
Align Technology (ALGN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Here, we discuss four stocks from the Dental Supplies industry that are likely to generate wealth for investors amid tariff uncertainty. These are MCK, CAH, WST and ALGN.
Align Technology, Inc. is upgraded to Hold after a 30% decline versus SPY's 74% gain over three years. ALGN faces stagnant sales, margin compression, and lackluster growth, with 2025 showing revenue and margin declines. Management guides for sequential improvement in Clear Aligner volume and ASP, with Q4 consensus broadly in line with company expectations.
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Align Technology (ALGN) is now rated Buy with a $180 target, offering ~10% upside after a significant correction and strong Q3 results. Q3 beat expectations: international demand and children's segment drove higher volumes, though average selling prices declined due to discounts and new markets. Adjusted operating margins improved to 23.9%, with aggressive buybacks and restructuring supporting EPS growth; GAAP margins impacted by one-time charges.
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.